HIV-1 gp120: A Target for Therapeutics and Vaccine Design.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Drug Targets

• Publication date

  2015-12-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389450116666150825120735PMID 26302793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Orientation of HIV-1 gp120 Binding to the CD4 Receptor Differentially Modulates CD4+ T Cell Activation

  2015cited by this paper
• Plasma membrane signaling in HIV-1 infection.

  2014cited by this paper
• Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines

  2014cited by this paper
• DC-SIGN, DC-SIGNR and LSECtin: C-Type Lectins for Infection

  2014cited by this paper
• HSV-2-Driven Increase in the Expression of α4β7 Correlates with Increased Susceptibility to Vaginal SHIVSF162P3 Infection

  2014cited by this paper
• Potential approaches to reverse or repair renal fibrosis

  2014cited by this paper
• Impact of Asymptomatic Herpes Simplex Virus Type 2 Infection on Mucosal Homing and Immune Cell Subsets in the Blood and Female Genital Tract

  2014cited by this paper
• HIV-1 Capture and Transmission by Dendritic Cells: The Role of Viral Glycolipids and the Cellular Receptor Siglec-1

  2014cited by this paper
• Envelope Glycoprotein Binding to the Integrin α4β7 Is Not a General Property of Most HIV-1 Strains

  2014cited by this paper
• Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection

  2014cited by this paper
• HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life

  2013cited by this paper
• Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV

  2013cited by this paper
• Development of small molecule HIV-1 fusion inhibitors: linking biology to chemistry.

  2013cited by this paper
• Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.

  2013cited by this paper
• Interferon-Inducible Mechanism of Dendritic Cell-Mediated HIV-1 Dissemination Is Dependent on Siglec-1/CD169

  2013cited by this paper
• Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection.

  2013cited by this paper
• Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and Potency Against HIV-1, With Natural Resistance Mediated by the Loss of a V5 Glycan in Envelope

  2013cited by this paper
• Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

  2013cited by this paper
• HIV-1 gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression

  2013cited by this paper
• Entry inhibitors and their use in the treatment of HIV-1 infection.

  2013cited by this paper
• Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

  2012cited by this paper
• Key Concepts in the Early Immunology of HIV-1 Infection

  2012cited by this paper
• Molecular mechanisms of HIV entry.

  2012cited by this paper
• Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus

  2012cited by this paper
• The changing face of HIV vaccine research

  2012cited by this paper
• The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission

  2011cited by this paper
• Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys

  2011cited by this paper
• Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins

  2011cited by this paper
• Characterization of a Human Cervical CD4+ T Cell Subset Coexpressing Multiple Markers of HIV Susceptibility

  2011cited by this paper
• Siglecs Facilitate HIV-1 Infection of Macrophages through Adhesion with Viral Sialic Acids

  2011cited by this paper
• Clinical use of CCR5 inhibitors in HIV and beyond

  2011cited by this paper
• HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

  2011cited by this paper
• Blocking of α4β7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques

  2011cited by this paper
• Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy

  2011cited by this paper
• B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.

  2011cited by this paper
• Targeting early infection to prevent HIV-1 mucosal transmission

  2010cited by this paper
• Toward an antibody-based HIV-1 vaccine.

  2010cited by this paper
• Monitoring α4β7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection

  2009cited by this paper
• HIV-1-specific antibody responses during acute and chronic HIV-1 infection

  2009cited by this paper
• Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection

  2009cited by this paper
• The immune response during acute HIV-1 infection: clues for vaccine development

  2009cited by this paper
• Human immunology of measles virus infection.

  2009cited by this paper
• Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

  2009cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

  2009cited by this paper
• Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection

  2009cited by this paper
• B cells in HIV infection and disease

  2009cited by this paper
• CD4 T cell subsets in the mucosa are CD28+Ki‐67−HLA‐DR−CD69+ but show differential infection based on α4β7 receptor expression during acute SIV infection

  2009cited by this paper
• The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1

  2009cited by this paper
• Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection

  2009cited by this paper
• Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1

  2009cited by this paper
• α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection

  2009cited by this paper
• Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

  2009cited by this paper
• The combination of the gastrointestinal integrin (α4β7) and selectin ligand enhances T-Cell migration to the reproductive tract during infection with Chlamydia trachomatis.

  2009cited by this paper
• Defective Plasmacytoid Dendritic Cell-NK Cell Cross-Talk in HIV Infection

  2009cited by this paper
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

  2008cited by this paper
• HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

  2008cited by this paper
• Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

  2008cited by this paper
• Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection.

  2008cited by this paper
• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

  2008cited by this paper
• Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

  2008cited by this paper
• HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

  2008cited by this paper
• Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques

  2008cited by this paper
• HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.

  2008cited by this paper
• Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?

  2007cited by this paper
• Broad-Spectrum Anti-Human Immunodeficiency Virus (HIV) Potential of a Peptide HIV Type 1 Entry Inhibitor

  2007cited by this paper
• HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.

  2006cited by this paper
• The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through Gαi-protein signalling

  2006cited by this paper
• Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant

  2006cited by this paper
• Diversity in HIV-1 Envelope V1–V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome But Does Not Predict the Extent of Sequence Diversity During Chronic Infection

  2006cited by this paper
• Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 Infection

  2006cited by this paper
• Interaction of human immunodeficiency virus (HIV) glycans with lectins of the human immune system.

  2006cited by this paper
• Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

  2006cited by this paper
• GP120: target for neutralizing HIV-1 antibodies.

  2006cited by this paper
• Perils at mucosal front lines for HIV and SIV and their hosts

  2005cited by this paper
• Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels

  2005cited by this paper
• The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection.

  2005cited by this paper
• Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

  2005cited by this paper
• HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine.

  2005cited by this paper
• G-Protein Signaling Triggered by R5 Human Immunodeficiency Virus Type 1 Increases Virus Replication Efficiency in Primary T Lymphocytes

  2005cited by this paper
• Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.

  2005cited by this paper
• Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

  2005cited by this paper
• Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction

  2005cited by this paper
• Natalizumab induction and maintenance therapy for Crohn's disease.

  2005cited by this paper
• Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

  2005cited by this paper
• Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-Type 1-Infected Individuals

  2004cited by this paper
• Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission

  2004cited by this paper
• CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

  2004cited by this paper
• Divide and conquer: the importance of cell division in regulating B‐cell responses

  2004cited by this paper
• Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

  2004cited by this paper
• Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population

  2004cited by this paper
• Increased HIV-1 Mucosal Replication Is Associated With Generalized Mucosal Cytokine Activation

  2004cited by this paper
• CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes1

  2004cited by this paper
• HIV-1 coreceptor usage, transmission, and disease progression.

  2003cited by this paper
• Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy

  2003cited by this paper
• HIV Envelope Induces Virus Expression from Resting CD4+ T Cells Isolated from HIV-Infected Individuals in the Absence of Markers of Cellular Activation or Apoptosis1

  2003cited by this paper
• Anatomical basis of tolerance and immunity to intestinal antigens

  2003cited by this paper
• Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function

  2003cited by this paper
• Neutralization of Human Immunodeficiency Virus Type 1 by sCD4-17b, a Single-Chain Chimeric Protein, Based on Sequential Interaction of gp120 with CD4 and Coreceptor

  2003cited by this paper
• DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.

  2003cited by this paper
• The role of dendritic cell C‐type lectin receptors in HIV pathogenesis

  2003cited by this paper

• Immunoinformatic-driven design and evaluation of multi-epitope mRNA vaccine targeting HIV-1 gp120

  2025cites this paper
• Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitors.

  2022cites this paper
• Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice

  2021cites this paper
• The Interplay of HIV and Autophagy in Early Infection

  2021cites this paper
• HIV-1 exposure promotes PKG1-mediated phosphorylation and degradation of stathmin to increase epithelial barrier permeability

  2021cites this paper
• Immunogenicity Evaluation of N-Glycans Recognized by HIV Broadly Neutralizing Antibodies.

  2021cites this paper
• High Level Stable Expression of Recombinant HIV gp120 in Glutamine Synthetase Gene Deficient HEK293T Cells.

  2021cites this paper
• Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mouse and Human.

  2020cites this paper
• Factors That Govern the Induction of Long-Lived Antibody Responses

  2020cites this paper
• In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoprotein

  2020cites this paper
• Antiviral Effects of Oleandrin

  2020cites this paper
• Viral evolution in a pediatric rhesus macaque model of HIV therapy and rebound

  2019cites this paper
• A high mucosal blocking score is associated with HIV protection

  2019cites this paper
• Study of Virus Infection Procedure using Atomic Force Microscope

  2019cites this paper
• Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?

  2018cites this paper
• HIV-1 GP160 (GP120/GP40) Trimer ENV Spike Protein

  2018cites this paper
• Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2

  2017cites this paper
• HIV-1 Envelope (ENV) GP160 Trimer Protein Complex SPIKE as a Recombinant Macromolecular Assembly Vaccine Component Candidate: Current Opinion

  2017cites this paper
• Short Oligopeptide T-Cell Epitopes in HIV-1/AIDS Vaccine Development: Current Status, Design, Promises and Challenges

  2017cites this paper
• Research on the process of virus infecting cells using atomic force microscope measuring mechanical properties

  year unknowncites this paper